Anti-fXI antibodies and methods of use

Details for Australian Patent Application No. 2009335643 (hide)

Owner Vanderbilt University Oregon Health & Science University

Inventors Gruber, Andras; Tucker, Erik I.; Gailani, David

Agent Fisher Adams Kelly

Pub. Number AU-A-2009335643

PCT Pub. Number WO2010/080623

Priority 61/138,590 18.12.08 US

Filing date 18 December 2009

Wipo publication date 15 July 2010

International Classifications

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/080623 Priority application(s): WO2010/080623

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335644-Thermal control system for an electronic display

2009335642-Drug delivery devices for delivery of therapeutic agents